secwatch / observer
8-K filed January 4, 2023, 6:59 PM ET ticker TCRT CIK 0001107421
regulatory confidence high sentiment negative materiality 0.70

Alaunos Therapeutics, Inc. (TCRT): Nasdaq/NYSE listing notice — Alaunos Therapeutics receives Nasdaq deficiency notice for bid price below $1.00

Alaunos Therapeutics, Inc.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Alaunos Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5450(a)(1), 5810(c)(3)(A)
Exact text from the filing
January 4, 2023, Alaunos Therapeutics, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”), had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the “Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(
View on SEC.gov

Browse all listing & compliance notices →

Alaunos Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-23-001563
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.